Brand Information

Updated On: 27-02-2024

Home

About Us

FAQs

Feedback

Disclaimer

Site Map

Home > Search > > Brand List By Indication > WYMOX

WYMOX

Brand:
WYMOX

Manufacturer:
WYETH

Manufacturer Details
WYETH

Compositions:
Amoxycillin 250mg/500mg capsules, Amoxycillin 250mg -DISTAB, Amoxycillin 125mg per 5ml - SUSPENSION,

Strength	Rate	Packing Style
250mg	35.81	10s capsules
500mg	100.09	10s capsules
250mg dis tab	133.10	15s DIS TAB
125m/ 5ml	51.13	30ml DRY SYRUP

List of Related Indications:

G.I. infection
Genito-urinary tract infection
Gram +ve gram -ve infections
Respiratory tract infection

List Of Drugs:

Amoxycillin @ - Aminopenicillins- ( FDC- List )- (June 1996))

Indication Type Description:

Drug Interaction

Indication

Adverse Reaction

Contra-Indications

Dosages/ Overdosage Etc

Other Information

Patient Information

Interaction with Food

Drug Interaction:

Penicillins include

Natural-

Penicillin G, Penicillin V Penicillase -Resistent- Cloxacillin, Docloxacillin, Methicillin, Nafacillin, Oxacillin

Aminopenicillins-

Amoxycillin, Amoxycillin/Potassium Clavulanate, Ampicillin, Ampicillin/Sulbactum, Becampicillin

Extended spectrum-

Carbenicilin, Mezlocillin, Piperacillin.Tazobactam sodium, Ticarcillin, Ticarcillin/Potassium clavulanate

Refer Penicillin V Potassium

May reduce absorption of oral contraceptives leading to break through bleeding or pregnancy.

Indication:

U.S.FDA APPROVED DRUGS FROM 01-01-08 TO 31-12-08

Drug name Indication Date of Approval

40. Amoxycillin 250mg/125mg 30-01-08

+ Cloxacillin 250mg/125mg

+ Lactobacillus Bacillus 1.7 Billion spores

For RTI, SRS. of tissue infection, bone & joint

infection, ENT infection in adults prone to

antibiotic diarrhoea

41. Amoxicillin 250mg 30-01-08

+ Lactobacillus 1.7 Billion spores

For RTI, SRS. of tissue infection, bone & joint

infection, ENT infection in adults prone to

antibiotic diarrhoea

45. Amoxicillin 250mg 30-01-08

+Cloxacillin 250mg

+ Lactobacillus 2 Billion sores capsules

For the treatment of lower RTI, skin & soft tissue

bone & joint infections, ENT infections in adult

patients prone to antibotic associated diarrhoea

68. Amoxucillin 125mg/250mg/500mg 31-01-08

+ Lactobacills

For the treatment of respiratory tract infection,

skin and soft tissue infections & antobiotics

associated diarrhoea

248. Amoxycillin 25-11-08

+ Clavulanic acid (1gm + 62.5mg)

FC tablets

For the treatment and management of patients

with community acquired pneumonia or acute

bacterial sinusitis due to beta lactamase

producing pathogens

U.S.FDA APPROVED DRUGS DURING 2006

62. Amoxycillin 1000mg 08-06-2006

+Clavulanate Potassium 62.5mg ER tablet Anti-biotic 112. Amoxycillin 250mg 28-08-2006

+ Dicloxacillin 250mg cap

Anti-biotic

FIXED DOSE COMBINATIONS APPROVED BY DCG(I)

FROM JANUARY 1961 TILL NOVEMBER 2014

Name of Drug Indication Date of Approval

1.Each 1ml of the constituted suspension contains- 14-10-2014

Amoxycillin Trihydrate IP eq. to Amoxycillin 80mg+

Potassium Clavulanate IP eq to Clavulanic acid 11.4mg

Addl.stgth

For the treatment of infections due to susceptible isolates

of the designated bacteria in the conditions such as lower

Respiratory Tract Infections , Acute Bacterial Otitis Media,

Skin and skin structure infections, Urinary Tract infections

in children more than 20kg body weight

2.Each 5ml of reconstituted suspension contains: 18-09-2014

Amoxicillin Trihydrate IP eq to Amoxicillin 200mg/400mg+

Potassium Clavulanate IP eq.to clavulanic acid 28.5mg/57mg

Addl.Stgth

For the treatment of bacterial infection such as Sinusitis Otitis

Media. Tonsilitis acute and chronic bronchtis, skin and soft

tissue infections and post operative pain

3. Each 5ml reconstituted syrup contains: 07-08-1990

Amoxycillin as trihydrate 125mg +

Clavulanic Acid 31.25mg as Potassium salt suspension

4.Each combipack contains: 14-10-2014

A- Each 5ml of constututed suspension contains:

i. Amoxicillin trihydrate IP eq.to Amoxicillin 200mg +

Potassium Clavulanate IP eq. to Clavulanic acid 28.5mg

ii. Amoxicillin rihydrate eq.to amoxicillin 400mg +

Potassium Clavulanate IP eq.to Clavulanic acid 57mg

B- One vial of purified water IP Each Vial contains

Purified water IP 30ml

Addl.Pack

For the treatment of bacterial infection such as Sinusitis

Otitis Media, Tonsilitis, Acute and chronic bronchitis ,

Skin and soft tissue infections and post operative pain

5. Potassium Calvulanic eq. to 05-04-1980

Clavulanic Acid 125mg +

Amoxycillin trihydrate

eq to Amoxycillin 250mg tablet

For the treatment of bacterial infections such as sinusitis.

ottitis media, tonsilitis, acute and chronic bronchitis,skin

post operative pain

6.Sterile Amoxycillin eq.to 21-06-1996

Amoxycillin 500gm/1gm +

Sterile Sulbatum eq.to

Sulbactum 250mg/500mg each vial inj

Antibiotic

Lower respiratory infections

Skin and soft tissue infection

Urinary tract infections

Post operative infection

Osteomylitis

Penicillins include

Natural-

Penicillin G, Penicillin V Penicillase -Resistent- Cloxacillin, Docloxacillin, Methicillin, Nafacillin, Oxacillin

Aminopenicillins-

Amoxycillin, Amoxycillin/Potassium Clavulanate, Ampicillin, Ampicillin/Sulbactum, Becampicillin

Extended spectrum-

Carbenicilin, Mezlocillin, Piperacillin.Tazobactam sodium, Ticarcillin, Ticarcillin/Potassium clavulanate

Refer Penicillin V Potassium

New drugs approved For Marketing by Drug Controller General of India(DCGI )

during the period January 1988 to November 2014

(Ref- IDMA Annual Publication 2015)

Name of Drug Indication Date of Approval

1. Amoxicillin 250mg + lacto-bacillus 1.7 billion 31-02-2008

spores

For RTI. SRS of soft tissue infection, bone and joint infection,

ENT infection, in adults prone to antibitic associated diarrhea

2.Amoxicilin 250mg/125mg + cloxaxillin 250mg/125mg + 30-01-2008

lactic acid bacillus 1.7 billion spores

For RTI. SRS of soft tissue infection, bone and joint infection,

ENT infection, in adults prone to antibitic associated diarrhea

3.Amoxicillin + Clavulanic acid 1gm + 62.6mg FC tabs 25-11-2008

For the treatment and mangement of patients with community

acquired pneumonia or acute bacterial sinusitis due to

beta lactamase producing pathogens

4.Amoxicillin 1000mg + Clavulanate potassium 62.5mg 08-06-2006

ER tablet

Anti-biotic

5. Amoxicillin 125mg/250mg/500mg + 31-01-2008

lactobacillus 1.66 billion spores capsules

For the treatment of respiratory tract infection, skin and soft

tissue infections and antibiotic associated diarrhea

in adult patients

6. Amoxicillin 250mg + Cloxacillin 250mg + Lactobacillus 30-01-2008

2 Billion spores capsules

For the treatment of lower RTI, skin and soft tissue bone and

joint infection, and ENT infections in adult patients prone to

antibiotic associated diarrhea

7.Amoxicilin 250mg + Dicloxacillin 250mg capsules 28-08-2006

Antibiotic

8. Amoxicillin oral suspension 200/400mg /5ml 09-08-2010

In the treatment of infections due to susceptible strains of the

designated micro-oragnanism in the condition of ENT infection,

skin and skin structure infection, lower respiratory tract infection,

Genito - urinary tract infection, Gonorrhea, acute uncomplicated

(anogenital and urethreal ) infections

Adverse Reaction:

Very rarely anaphylactic shock may occur.

Hypersens, maculopapular rash, diarrhoea, resistence, pseudo-membranous colitis.

Contra-Indications:

Hypersens to penicillins,infectious mononucleosis.

Special precautions:

Gastric ulcer.

Assess renal, hepatic or haemopoietic fuctions periodically in prolonged therapy.

Dosages/ Overdosage Etc:

Indication-

Lower respiratory infections

Skin and soft tissue infection

Urinary tract infections

Post operative infection Osteomylitis

Dosage:

The activity and dosage similar to Ampicillin,except that Ampicillin is more effective against Spigella sps. Amoxycillin has the advantage of more complete apsorption than Ampicilln

A dose of 3 times a day for most infections and less diarrhoea than Ampicillin..

Stability same as ampicillin.

Missed dose

1. If you miss a dose of this medicine take it as soon as possible. This will help to keep a constant amount of medicine in the blood or urine.

2. However, if it is almost time for your next dose skip the next dose and go back to your regular dosing schedule.

3. Do not double doses.

Other Information:

For Availability/supplies

Contact -

1.Indian Drug Manufacturers Association (IDMA)

Phone- 022- 24944624/ 24974308

Fax- 022- 24950723

Email- idma@vsnl.com

Website: www.idma-assn.org

2.Bulk Drug Manufacturers Association (India)(BDMA)

Phone - 040-23703910/ 23706718

Fax- 040-23704804

Email- info@bdmai.org

Website: www.info@bdmai.org

Patient Information:

May be taken with meals for better absorption and reduce GI discomfort

Interaction with Food: